Vaccine efficacies against EV@-associated hospitalization ( @ cases vs. @ cases ) and hand , foot , and mouth disease with neurologic complications ( @ cases vs. @ cases ) were both @ % ( @ % CI , @ to @ and @ to @ , respectively ) .